News

Seracam® Abstract Accepted at SNMMI on Sentinel Lymph Node Biopsy Imaging Study

By Serac Life Sciences

Seracam® Abstract Accepted at SNMMI on Sentinel Lymph Node Biopsy Imaging Study Read More »

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent – Positive Feedback on Phase III Trial Design –

By Serac Life Sciences

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent – Positive Feedback on Phase III Trial Design – Read More »

DETECT abstract accepted at World Congress on Endometriosis 2025

By Serac Life Sciences

DETECT abstract accepted at World Congress on Endometriosis 2025 Read More »

DETECT Endometriosis Imaging Study Presented at EANM’24

By Serac Life Sciences

DETECT Endometriosis Imaging Study Presented at EANM’24 Read More »

First Clinical Results Using Seracam® for Small Organ Imaging Presented at EANM’24

By Serac Life Sciences

First Clinical Results Using Seracam® for Small Organ Imaging Presented at EANM’24 Read More »

Seracam® Demonstrates Feasibility for Sentinel Lymph Node Imaging at IPET 2024

By Serac Life Sciences

Seracam® Demonstrates Feasibility for Sentinel Lymph Node Imaging at IPET 2024 Read More »

Poster Presented at MICCAI on AI Joint Classification of Images using 99mTc-Maraciclatide

By Serac Life Sciences

Poster Presented at MICCAI on AI Joint Classification of Images using 99mTc-Maraciclatide Read More »

EANM DETECT Abstract Published and Presentation Details

By Serac Life Sciences

EANM DETECT Abstract Published and Presentation Details Read More »

Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease

By Serac Life Sciences

Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease Read More »

Paper Accepted at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide

By Serac Life Sciences

Paper Accepted at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide Read More »